Fig. 6

FACS analysis of CD3+/FoxP3+ Tregs in (a) Cisplatin untreated SPDCs stimulated co-cultures (b) Cisplatin treated (150 μM) SPDCs stimulated co-cultures (c) Bar graphs indicate CD3+/ FoxP3+Tregs ratio in SPDCs stimulated co-cultures treated with three different doses of cisplatin treated SPDCs (P = 0.340; P10–P12)